Home › Pemphigus
Pemphigus clinical trials recruiting in the U.S.
6 studies for Pemphigus are recruiting participants at sites across the United States.
Pemphigus and bullous pemphigoid are an autoimmune disorder, affects cells in your skin and mouth. Learn about symptoms, diagnosis, and treatment.
Cities with the most studies
By state
Recently updated studies
A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 15, 2026 · NCT04422912Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
RecruitingPhase 1
Ages 18 to 85 · All sexes · Updated Jul 22, 2026 · NCT06371417A Study to Investigate Safety and Efficacy of KB111 for the Treatment of Hailey-Hailey Disease
RecruitingEarly phase 1
Ages 12 and older · All sexes · Updated Jul 21, 2026 · NCT07717346Efficacy of Guselkumab in Treating Hailey Hailey Disease
RecruitingPhase 2Healthy volunteers welcome
Ages 18 to 90 · All sexes · Updated Jun 22, 2026 · NCT06651489Autoimmune Blistering Diseases Study
RecruitingObservational study
Ages 18 and older · All sexes · Updated Mar 30, 2026 · NCT02753777Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associated Autoimmune Diseases.
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 3, 2024 · NCT06581562From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.